Proinsulin peptide immunotherapy in type 1 diabetes:safety data of a first in new-onset type 1 diabetes phase 1b trialMohammad Alhadj Ali, Colin M Dayan, Rachel Stenson et al.|Research Portal (King's College London)|2015Cited by 0